Seoul, South Korea

Hyounmie Doh



Average Co-Inventor Count = 12.5

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Seoul, KR (2003 - 2017)
  • Yongin-si, KR (2023)

Company Filing History:


Years Active: 2003-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Hyounmie Doh

Introduction

Hyounmie Doh is a notable inventor based in Seoul, South Korea, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, he has made strides in developing innovative solutions for cancer treatment.

Latest Patents

Among Hyounmie Doh's latest patents is the "Anti-DR5 antibody and use thereof." This invention pertains to an antibody that specifically binds to death receptor 5 (DR5) and demonstrates a unique capability of killing cancer cells. The invention is remarkable for its improved affinity to DR5, stability, and its efficacy in eliminating cancer cells.

Another significant patent is the "Anti-VEGF antibody and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases." This patent introduces a novel anti-vascular endothelial growth factor (VEGF) antibody that exhibits a strong binding affinity for VEGF. It has shown the ability to inhibit in vivo tumor growth, suppress the proliferation and permeability of human umbilical vein endothelial cells (HUVEC), and therefore holds promise as a therapeutic antibody for cancer treatment.

Career Highlights

Hyounmie Doh has had a prominent career with key roles at esteemed companies such as Dong-A ST Co., Ltd. and Dong-A Pharm. Co., Ltd. His work in these organizations has greatly influenced the development of cancer therapeutics, reinforcing his status as a pioneering figure in biotechnology.

Collaborations

Throughout his career, Hyounmie has collaborated with several talented individuals, including Dongsop Lee and Moohi Yoo. These partnerships have facilitated significant advancements in their research efforts and have contributed to the success of their innovative projects.

Conclusion

Hyounmie Doh exemplifies the essence of innovation in the field of cancer research. By developing groundbreaking antibodies, he has positioned himself as a key player in the ongoing fight against cancer. His contributions not only advance scientific knowledge but also pave the way for new treatment options that can benefit countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…